RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 107 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $14,715,000 | +14.2% | 4,921,487 | +1.3% | 0.37% | +24.2% |
| Q4 2021 | $12,880,000 | -26.0% | 4,860,200 | +1.4% | 0.30% | -18.6% |
| Q3 2021 | $17,400,000 | -15.7% | 4,793,400 | +0.8% | 0.37% | -10.3% |
| Q2 2021 | $20,636,000 | +27.2% | 4,754,900 | +0.3% | 0.41% | +15.3% |
| Q1 2021 | $16,218,000 | -2.3% | 4,742,000 | -0.0% | 0.35% | +0.6% |
| Q4 2020 | $16,600,000 | +45.8% | 4,742,891 | 0.0% | 0.35% | +21.8% |
| Q3 2020 | $11,383,000 | +5.5% | 4,742,891 | -19.6% | 0.29% | -2.4% |
| Q2 2020 | $10,793,000 | +25.8% | 5,897,642 | +7.2% | 0.30% | -16.6% |
| Q1 2020 | $8,580,000 | -27.1% | 5,500,000 | +0.0% | 0.36% | -4.6% |
| Q4 2019 | $11,766,000 | +49.8% | 5,497,900 | +30.9% | 0.37% | +18.8% |
| Q3 2019 | $7,854,000 | -28.4% | 4,200,000 | 0.0% | 0.31% | -21.2% |
| Q2 2019 | $10,962,000 | +1.6% | 4,200,000 | 0.0% | 0.40% | -4.6% |
| Q1 2019 | $10,794,000 | +11.7% | 4,200,000 | 0.0% | 0.42% | -8.8% |
| Q4 2018 | $9,660,000 | -27.0% | 4,200,000 | +1.8% | 0.46% | -4.8% |
| Q3 2018 | $13,241,000 | +18.4% | 4,125,000 | +4.4% | 0.48% | +11.4% |
| Q2 2018 | $11,179,000 | +22.6% | 3,950,000 | +53.4% | 0.43% | +10.5% |
| Q1 2018 | $9,116,000 | -5.1% | 2,575,000 | +4.0% | 0.39% | -10.8% |
| Q4 2017 | $9,603,000 | +278.1% | 2,475,000 | +147.5% | 0.44% | +272.6% |
| Q3 2017 | $2,540,000 | -7.0% | 1,000,000 | 0.0% | 0.12% | -15.2% |
| Q2 2017 | $2,730,000 | -17.5% | 1,000,000 | 0.0% | 0.14% | -27.7% |
| Q1 2017 | $3,310,000 | +39.1% | 1,000,000 | 0.0% | 0.19% | +20.1% |
| Q4 2016 | $2,380,000 | -64.2% | 1,000,000 | -44.8% | 0.16% | -61.8% |
| Q3 2016 | $6,643,000 | +70.2% | 1,810,000 | +3.4% | 0.42% | +43.9% |
| Q2 2016 | $3,903,000 | +28.2% | 1,750,000 | +19.5% | 0.29% | +13.3% |
| Q1 2016 | $3,045,000 | -8.6% | 1,464,050 | +33.1% | 0.26% | +0.8% |
| Q4 2015 | $3,333,000 | – | 1,100,000 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 1,500,000 | $1,620,000 | 1.72% |
| Soleus Capital Management, L.P. | 14,803,015 | $15,987,256 | 1.48% |
| ARMISTICE CAPITAL, LLC | 17,136,000 | $18,506,880 | 0.28% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,228,126 | $1,326,376 | 0.24% |
| GSA CAPITAL PARTNERS LLP | 971,441 | $1,049 | 0.09% |
| NJ State Employees Deferred Compensation Plan | 200,000 | $216,000 | 0.03% |
| Providence Wealth Advisors, LLC | 27,500 | $29,013 | 0.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,151,765 | $1,243,906 | 0.03% |
| XTX Topco Ltd | 164,238 | $177,377 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 3,369,076 | $3,638,602 | 0.02% |